等待开盘 09-29 09:30:00 美东时间
0.000
0.00%
LB Pharmaceuticals appoints William Kane and Rekha Hemrajani to its Board, adding expertise in finance and commercialization. Their additions aim to support LB-102, a potential first benzamide antipsychotic, through Phase 3 and Phase 2 trials for schizophrenia and bipolar depression. With decades of experience in drug development, Kane and Hemrajani will strengthen the company's strategic growth as it advances its lead product. LB-102's promising...
09-25 12:30
LB Pharmaceuticals Inc. announced the pricing of its upsized initial public offering of 19,000,000 shares of common stock at $15.00 per share, expected to raise $285.0 million before deductions. The underwriters have a 30-day option to purchase an additional 2,850,000 shares. Trading will begin on the Nasdaq Global Market on September 11, 2025, under the ticker symbol "LBRX," with the offering closing on September 12, 2025. Leerink Partners, Pipe...
09-11 01:03
核能投资热潮席卷全球!Oklo周涨99.2%;比特币升破68000美元,加密矿商CleanSpark周涨34.1%>>
2024-10-19 18:27
星舰第五次试飞成功!实现筷子夹火箭,持仓SpaceX的资管公司DXYZ隔夜涨21%;美国大选临近,市场回归“特朗普交易”,DJT隔夜涨18.5%>>
2024-10-15 18:42
Longboard Pharmaceuticals ($LBPH) soared in trading on Monday after announcing ...
2024-10-15 00:39
Cantor Fitzgerald analyst Josh Schimmer downgrades Longboard Pharmaceuticals (NASDAQ:LBPH) from Overweight to Neutral.
2024-10-14 23:14
Longboard股价在美股盘前交易中的涨幅拆过超过50%。
2024-10-14 20:00
Truist Securities initiated coverage on Longboard Pharmaceuticals, citing it as a CNS-focused biotech with high-value epilepsy assets.
2024-09-11 02:13
Evercore ISI Group analyst Josh Schimmer maintains Longboard Pharmaceuticals (NASDAQ:LBPH) with a Outperform and maintains $80 price target.
2024-08-26 22:58